Enhanced Chemokine Receptor Expression on Leukocytes of Patients with Alzheimer's Disease

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Goldeck, David ^a   Larbi, Anis ^b   Pellicanó, Mariavaleria ^a   Alam, Iftikhar ^a,c   Zerr, Inga ^d   Schmidt, Christian ^d   Fulop, Tamas ^e   Pawelec, Graham ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b AGENCY FOR SCIENCE   (Singapore)

^c ABDUL WALI KHAN UNIVERSITY   (Pakistan)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

^e UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; INTERLEUKIN 2 RECEPTOR ALPHA;

AGED; ALZHEIMER DISEASE; ARTICLE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE STATUS; LEUKOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MALE; MEMORY CELL; PHENOTYPE; PROTEIN EXPRESSION; TH1 CELL; TH17 CELL; TH2 CELL; CASE CONTROL STUDY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM;

ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKOCYTES; MALE; RECEPTORS, CHEMOKINE;

EID: 84879141115     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066664     Document Type: Article

References (41)

1. Togo T, Akiyama H, Iseki E, Kondo H, Ikeda K, et al. (2002) Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases. J Neuroimmunol 124: 83-92.
2. Alt C, Laschinger M, Engelhardt B, (2002) Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis. Eur J Immunol 32: 2133-2144.
3. Alter A, Duddy M, Hebert S, Biernacki K, Prat A, et al. (2003) Determinants of human B cell migration across brain endothelial cells. J Immunol 170: 4497-4505.
4. Weksler BB, Subileau EA, Perriere N, Charneau P, Holloway K, et al. (2005) Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 19: 1872-1874.
5. Kovac A, Zilkova M, Deli MA, Zilka N, Novak M, (2009) Human truncated tau is using a different mechanism from amyloid-beta to damage the blood-brain barrier. J Alzheimers Dis 18: 897-906.
6. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM, (2002) B cells regulate autoimmunity by provision of IL-10. Nat Immunol 3: 944-950.
7. Deane R, Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, et al. (2003) RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 9: 907-913.
8. Silverberg GD, Messier AA, Miller MC, Machan JT, Majmudar SS, et al. (2010) Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging. J Neuropathol Exp Neurol 69: 1034-1043.
9. Silverberg GD, Miller MC, Messier AA, Majmudar S, Machan JT, et al. (2010) Amyloid deposition and influx transporter expression at the blood-brain barrier increase in normal aging. J Neuropathol Exp Neurol 69: 98-108.
10. Li M, Shang DS, Zhao WD, Tian L, Li B, et al. (2009) Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier. J Immunol 182: 5778-5788.
11. Liu YJ, Guo DW, Tian L, Shang DS, Zhao WD, et al. (2010) Peripheral T cells derived from Alzheimer's disease patients overexpress CXCR2 contributing to its transendothelial migration, which is microglial TNF-alpha-dependent. Neurobiol Aging 31: 175-188.
12. Conductier G, Blondeau N, Guyon A, Nahon JL, Rovere C, (2010) The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. J Neuroimmunol 224: 93-100.
13. Correa JD, Starling D, Teixeira AL, Caramelli P, Silva TA, (2011) Chemokines in CSF of Alzheimer's disease patients. Arq Neuropsiquiatr 69: 455-459.
14. Fiala M, Zhang L, Gan X, Sherry B, Taub D, et al. (1998) Amyloid-beta induces chemokine secretion and monocyte migration across a human blood-rain barrier model. Mol Med 4: 480-489.
15. Westermann J, Pabst R, (1996) How organ-specific is the migration of 'naïve' and 'memory' T cells? Immunology today 17: 278-282.
16. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, et al. (2007) Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6: 734-746.
17. Alam I, Goldeck D, Larbi A, Pawelec G, (2012) Flow cytometric lymphocyte subset analysis using material from frozen whole blood. J Immunoassay Immunochemistry 33: 128-139.
18. Reale M, Iarlori C, Feliciani C, Gambi D, (2008) Peripheral chemokine receptors, their ligands, cytokines and Alzheimer's disease. J Alzheimers Dis 14: 147-159.
19. Lee KS, Chung JH, Choi TK, Suh SY, Oh BH, et al. (2009) Peripheral cytokines and chemokines in Alzheimer's disease. Dement Geriatr Cogn Disord 28: 281-287.
20. Town T, Tan J, Flavell RA, Mullan M, (2005) T-cells in Alzheimer's disease. Neuromolecular Med 7: 255-264.
21. Larbi A, Pawelec G, Witkowski JM, Schipper HM, Derhovanessian E, et al. (2009) Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer's disease. J Alzheim Dis 17: 91-103.
22. Pellicano M, Larbi A, Goldeck D, Colonna-Romano G, Buffa S, et al. (2011) Immune profiling of Alzheimer patients. J Neuroimmunol 242: 52-9.
23. Alam I, Goldeck D, Larbi A, Pawelec G (2012) Aging affects the proportions of T and B cells in a group of elderly men in a developing country-a pilot study from Pakistan. Age: Epub ahead of print.
24. Pellicano M, Bulati M, Buffa S, Barbagallo M, Di Prima A, et al. (2010) Systemic immune responses in Alzheimer's disease: in vitro mononuclear cell activation and cytokine production. J Alzheimers Dis 21: 181-192.
25. Lee YK, Kwak DH, Oh KW, Nam SY, Lee BJ, et al. (2009) CCR5 deficiency induces astrocyte activation, Abeta deposit and impaired memory function. Neurobiol Learn Mem 92: 356-363.
26. Glass WG, Lane TE, (2003) Functional expression of chemokine receptor CCR5 on CD4(+) T cells during virus-induced central nervous system disease. J Virol 77: 191-198.
27. Sorce S, Myburgh R, Krause KH, (2011) The chemokine receptor CCR5 in the central nervous system. Progr Neurobiol 93: 297-311.
28. Sallusto F, Impellizzieri D, Basso C, Laroni A, Uccelli A, et al. (2012) T-cell trafficking in the central nervous system. Immunol Rev 248: 216-227.
29. Reboldi A, Coisne C, Baumjohann D, Benvenuto F, Bottinelli D, et al. (2009) C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 10: 514-523.
30. Subramanian S, Ayala P, Wadsworth TL, Harris CJ, Vandenbark AA, et al. (2010) CCR6: a biomarker for Alzheimer's-like disease in a triple transgenic mouse model. J Alzheim Dis 22: 619-629.
31. El Khoury J, Toft M, Hickman SE, Means TK, Terada K, et al. (2007) Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med 13: 432-438.
32. Mildner A, Schmidt H, Nitsche M, Merkler D, Hanisch UK, et al. (2007) Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat Neurosci 10: 1544-1553.
33. Westin K, Buchhave P, Nielsen H, Minthon L, Janciauskiene S, et al. (2012) CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer's disease. PLoS One 7: e30525.
34. Man SM, Ma YR, Shang DS, Zhao WD, Li B, et al. (2007) Peripheral T cells overexpress MIP-1alpha to enhance its transendothelial migration in Alzheimer's disease. Neurobiol Aging 28: 485-496.
35. Torcia M, Bracci-Laudiero L, Lucibello M, Nencioni L, Labardi D, et al. (1996) Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 85: 345-356.
36. Noda M, Suzumura A, (2012) Sweepers in the CNS: Microglial Migration and Phagocytosis in the Alzheimer Disease Pathogenesis. Int J Alzheim Dis 2012: 891087.
37. Zaghi J, Goldenson B, Inayathullah M, Lossinsky AS, Masoumi A, et al. (2009) Alzheimer disease macrophages shuttle amyloid-beta from neurons to vessels, contributing to amyloid angiopathy. Acta Neuropathol 117: 111-124.
38. Fiala M, Lin J, Ringman J, Kermani-Arab V, Tsao G, et al. (2005) Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. J Alzheim Dis 7: 221-232.
39. Malm TM, Koistinaho M, Parepalo M, Vatanen T, Ooka A, et al. (2005) Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice. Neurobiol Dis 18: 134-142.
40. Simard AR, Soulet D, Gowing G, Julien JP, Rivest S, (2006) Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49: 489-502.
41. Cameron B, Landreth GE, (2010) Inflammation, microglia, and Alzheimer's disease. Neurobiol Dis 37: 503-509.